INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 110 filers reported holding INTERSECT ENT INC in Q2 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $15,538,000 | +184.8% | 554,744 | +177.7% | 0.11% | +202.9% |
Q4 2021 | $5,455,000 | +1020.1% | 199,744 | +898.7% | 0.04% | +600.0% |
Q1 2020 | $487,000 | -2.2% | 20,000 | 0.0% | 0.01% | 0.0% |
Q4 2019 | $498,000 | -26.8% | 20,000 | -50.0% | 0.01% | -44.4% |
Q3 2019 | $680,000 | -24.9% | 40,000 | 0.0% | 0.01% | -18.2% |
Q2 2019 | $906,000 | -6.1% | 40,000 | +33.3% | 0.01% | -8.3% |
Q1 2019 | $965,000 | +14.2% | 30,000 | 0.0% | 0.01% | -7.7% |
Q4 2018 | $845,000 | -2.1% | 30,000 | 0.0% | 0.01% | +18.2% |
Q3 2018 | $863,000 | -23.2% | 30,000 | 0.0% | 0.01% | -38.9% |
Q2 2018 | $1,124,000 | -4.7% | 30,000 | 0.0% | 0.02% | -10.0% |
Q1 2018 | $1,179,000 | +10.3% | 30,000 | -9.1% | 0.02% | +11.1% |
Q4 2017 | $1,069,000 | +9.3% | 33,000 | -5.7% | 0.02% | 0.0% |
Q2 2017 | $978,000 | -38.7% | 35,000 | -62.4% | 0.02% | -41.9% |
Q1 2017 | $1,595,000 | +62.8% | 93,000 | +14.8% | 0.03% | +40.9% |
Q4 2016 | $980,000 | -7.6% | 81,000 | +20.9% | 0.02% | -15.4% |
Q3 2016 | $1,061,000 | – | 67,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,332,773 | $27,828,000 | 5.75% |
First Light Asset Management, LLC | 2,036,645 | $42,525,000 | 2.82% |
Altium Capital Management LP | 141,856 | $2,962,000 | 0.82% |
PURA VIDA INVESTMENTS, LLC | 909,660 | $18,994,000 | 0.54% |
Rock Springs Capital Management LP | 1,080,200 | $22,555,000 | 0.49% |
Novo Holdings A/S | 508,922 | $10,626,000 | 0.44% |
Davide Leone & Partners Investment Co Ltd. | 109,240 | $2,281,000 | 0.28% |
PURA VIDA INVESTMENTS, LLC | 256,800 | $5,362,000 | 0.15% |
Bellevue Group AG | 617,968 | $12,903,000 | 0.14% |
Gyon Technologies Capital Management, LP | 13,318 | $278,000 | 0.12% |